Compound ID | 1504
Class: Nitroimidazole
Spectrum of activity: | Gram-positive |
Details of activity: | Effective against C. difficile and Fusobacterium infections. Only effective against anaerobic bacteria. |
Institute where first reported: | Pfizer, USA |
Year first mentioned: | 1960 |
Highest developmental phase: | Approved by FDA in 1995 |
Development status: | Approved |
Reason Dropped: | Other formulations were discontinued |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/4173 |
Guide to Pharmacology: | metronidazole |
Citations: |
|